Publication | Closed Access

Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV

OncologyGastrointestinal OncologyMedicineAdjuvant Folfox IvPathologyColorectal CancerColorectal Cancer PatientsClinical Predictive FactorsPharmacologyRadiation Oncology